Search - tctmd.com

Displaying 401 - 420 of 462

Sort: Relevancy | Date

News Industry News

Tryton Presents Positive Data from More Than 900 Patients at TCT 2012 Conference in Miami

October 29, 2012

News Industry News

Study Finds Drug-Eluting Stents Exhibit Some Benefits Over Bare-Metal Stents In Patients Over 80, Though Both Demonstrate Clinical Benefit

October 26, 2012

Presentation TCT 2012

Cases 7 and 8: FFR in Non-Left Main Bifurcation Lesions

Presenter: Nick Curzen

October 25, 2012

News Conference News TCT 2012

Experts Discuss Need for Development of Next-Generation DES, Insights from Pathology

October 24, 2012

Presentation TCT 2012

TCT-71. Intravascular Ultrasound-guided Systematic Two-stent Techniques for Coronary Bifurcation Lesions Reduced Late Stent Thrombosis and ST-elevation Myocardial Infarction

Presenter: Shao Liang Chen

October 23, 2012

Presentation TCT 2012

Complex Lesions: Bifurcations and CTOs

Presenter: David Kandzari

October 23, 2012

Presentation TCT 2012

Uses of Drug-Eluting Balloons for Coronary Bifurcation Lesions: Rationale, Data, and Practice

Presenter: Detlef Mathey

October 22, 2012

Presentation TCT 2012

Randomized Trials Don't Reflect the Real World: Two Stents Should Be Used 50% of Bifurcation Lesions or More!

Presenter: Antonio Colombo

October 22, 2012

Presentation TCT 2012

The Data Are Clear: The Careful Operator Should Implant Two Stents in No More Than 10% of Bifurcation Lesions!

Presenter: Liliana Grinfeld

October 22, 2012

News Industry News

Eurocor’s DEBIFU Registry successfully enrolled first patients

September 24, 2012

News Daily News

Pantoprazole Not Necessarily a Safer PPI Choice for Patients on Dual Antiplatelet Therapy

L.A. McKeown

August 01, 2012

News Daily News

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

L.A. McKeown

July 30, 2012

News Industry News

Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe

May 15, 2012

Presentation TCT Mediterranean 2012

Safety Issues with Bifurcation Lesions

Presenter: George D. Dangas

May 04, 2012

Presentation TCTAP 2012

Why FFR and Why Not FFR in Bifurcation Lesions

Presenter: Bon-Kwon Koo

April 26, 2012

News Daily News

Residual Syntax Score Predicts Outcome After Incomplete Revascularization

L.A. McKeown

April 10, 2012

News Daily News

PCI for Left Main Disease Uncommon in US Clinical Practice

Jason Kahn

March 23, 2012

News Daily News

OCT Shows Modest Ability to Identify Hemodynamically Severe Lesions

L.A. McKeown

March 15, 2012

News Daily News

PEPCAD-DES: Paclitaxel-Coated Balloon Bests Plain Balloon for DES Restenosis

March 05, 2012

News Daily News

Resolute Integrity: New Zotarolimus-Eluting Stent Gains FDA Approval

L.A. McKeown

February 20, 2012

Advertisement

Tryton Presents Positive Data from More Than 900 Patients at TCT 2012 Conference in Miami

Study Finds Drug-Eluting Stents Exhibit Some Benefits Over Bare-Metal Stents In Patients Over 80, Though Both Demonstrate Clinical Benefit

Cases 7 and 8: FFR in Non-Left Main Bifurcation Lesions

Experts Discuss Need for Development of Next-Generation DES, Insights from Pathology

TCT-71. Intravascular Ultrasound-guided Systematic Two-stent Techniques for Coronary Bifurcation Lesions Reduced Late Stent Thrombosis and ST-elevation Myocardial Infarction

Complex Lesions: Bifurcations and CTOs

Uses of Drug-Eluting Balloons for Coronary Bifurcation Lesions: Rationale, Data, and Practice

Randomized Trials Don't Reflect the Real World: Two Stents Should Be Used 50% of Bifurcation Lesions or More!

The Data Are Clear: The Careful Operator Should Implant Two Stents in No More Than 10% of Bifurcation Lesions!

Eurocor’s DEBIFU Registry successfully enrolled first patients

Pantoprazole Not Necessarily a Safer PPI Choice for Patients on Dual Antiplatelet Therapy

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe

Safety Issues with Bifurcation Lesions

Why FFR and Why Not FFR in Bifurcation Lesions

Residual Syntax Score Predicts Outcome After Incomplete Revascularization

PCI for Left Main Disease Uncommon in US Clinical Practice

OCT Shows Modest Ability to Identify Hemodynamically Severe Lesions

PEPCAD-DES: Paclitaxel-Coated Balloon Bests Plain Balloon for DES Restenosis

Resolute Integrity: New Zotarolimus-Eluting Stent Gains FDA Approval

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content